Previously dubbed Orphan, the series is inspired by the true story of Natalia Grace and the Midwestern couple who adopted her believing she was a little girl with dwarfism but gradually started to ...
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...
It’s time to move on from treating heroin as Europe’s main drug problem, according to the head of the European Union’s drugs agency. That’s not to say heroin isn’t still a major problem.
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...
DUBLIN--(BUSINESS WIRE)--The "Orphan ... number of regulatory frameworks aimed at fast-tracking the approval process for these treatments. As a result, regulatory bodies like the U.S. Food and ...
Some online sites are prescribing men a hair loss drug that has potentially risky side effects without consistent safety checks, the BBC has found. The side effects of finasteride can include ...
Ahmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration (USFDA) has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral ...
Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday ...
Drug maker Zydus Lifesciences, on Wednesday announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of a rare disease called ...
Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results